523 related articles for article (PubMed ID: 23114367)
41. Determinants of neuronal vulnerability in neurodegenerative diseases.
Morrison BM; Hof PR; Morrison JH
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S32-44. PubMed ID: 9749571
[TBL] [Abstract][Full Text] [Related]
42. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients.
Nihei K; McKee AC; Kowall NW
Acta Neuropathol; 1993; 86(1):55-64. PubMed ID: 8396837
[TBL] [Abstract][Full Text] [Related]
43. Is amyotrophic lateral sclerosis a primary astrocytic disease?
Sica RE
Med Hypotheses; 2012 Dec; 79(6):819-22. PubMed ID: 23026704
[TBL] [Abstract][Full Text] [Related]
44. Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis.
Buttarelli FR; Circella A; Pellicano C; Pontieri FE
Eur J Neurol; 2006 Apr; 13(4):416-8. PubMed ID: 16643322
[TBL] [Abstract][Full Text] [Related]
45. Longitudinal study of functional spinal alpha motor neuron loss in amyotrophic lateral sclerosis.
Arasaki K; Kato Y; Hyodo A; Ushijima R; Tamaki M
Muscle Nerve; 2002 Apr; 25(4):520-6. PubMed ID: 11932969
[TBL] [Abstract][Full Text] [Related]
46. Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.
Milinis K; Tennant A; Mills RJ; Al-Chalabi A; Burke G; Dick DJ; Ealing J; Hanemann CO; Harrower T; McDermott CJ; Majeed T; Pinto A; Talbot K; Williams T; Young CA;
Acta Neurol Scand; 2018 Jul; 138(1):47-54. PubMed ID: 29468643
[TBL] [Abstract][Full Text] [Related]
47. Ascorbate availability and neurodegeneration in amyotrophic lateral sclerosis.
Kok AB
Med Hypotheses; 1997 Apr; 48(4):281-96. PubMed ID: 9160282
[TBL] [Abstract][Full Text] [Related]
48. Luyso-pallido-nigral atrophy and amyotrophic lateral sclerosis.
Gray F; Eizenbaum JF; Gherardi R; Degos JD; Poirier J
Acta Neuropathol; 1985; 66(1):78-82. PubMed ID: 3993336
[TBL] [Abstract][Full Text] [Related]
49. Primary lateral sclerosis: a case report.
Beal MF; Richardson EP
Arch Neurol; 1981 Oct; 38(10):630-3. PubMed ID: 7295106
[TBL] [Abstract][Full Text] [Related]
50. No transneuronal degeneration between human cortical motor neurons and spinal motor neurons.
Terao S; Li M; Hashizume Y; Mitsuma T; Sobue G
J Neurol; 1999 Jan; 246(1):61-2. PubMed ID: 9987718
[No Abstract] [Full Text] [Related]
51. [Process of retrograde axonal degeneration in amyotrophic lateral sclerosis in the light of clinical electrophysiological studies].
Niewiadomska M; Wochnik-Dyjas D
Neurol Neurochir Pol; 1983; 17(1):7-15. PubMed ID: 6877502
[TBL] [Abstract][Full Text] [Related]
52. Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the Kii Peninsula (Japan).
Araki S; Iwahashi Y; Kuroiwa Y
J Neurol Sci; 1967; 4(2):279-87. PubMed ID: 6037097
[No Abstract] [Full Text] [Related]
53. Upper and Lower Motor Neuron Degenerations Are Somatotopically Related and Temporally Ordered in the
Marques C; Burg T; Scekic-Zahirovic J; Fischer M; Rouaux C
Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33805792
[TBL] [Abstract][Full Text] [Related]
54. [Huntington's chorea--amyotrophic lateral sclerosis-spastic spinal paralysis. Association of systemic diseases (author's transl)].
Frank G; Vuia O
Z Neurol; 1973 Nov; 205(3):207-20. PubMed ID: 4129046
[No Abstract] [Full Text] [Related]
55. Amyotrophic Lateral Sclerosis and the Respiratory System.
Braun AT; Caballero-Eraso C; Lechtzin N
Clin Chest Med; 2018 Jun; 39(2):391-400. PubMed ID: 29779597
[TBL] [Abstract][Full Text] [Related]
56. SEROTONIN AND AMYOTROPHIC LATERAL SCLEROSIS.
Kekenadze M; Kvirkvelia N; Beridze M; Vashadze S
Georgian Med News; 2024 Mar; (348):87-90. PubMed ID: 38807398
[TBL] [Abstract][Full Text] [Related]
57. An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's Disease.
de Paula CZ; Gonçalves BD; Vieira LB
Biomed Res Int; 2015; 2015():198612. PubMed ID: 26295035
[TBL] [Abstract][Full Text] [Related]
58. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis.
Palamiuc L; Schlagowski A; Ngo ST; Vernay A; Dirrig-Grosch S; Henriques A; Boutillier AL; Zoll J; Echaniz-Laguna A; Loeffler JP; René F
EMBO Mol Med; 2015 May; 7(5):526-46. PubMed ID: 25820275
[TBL] [Abstract][Full Text] [Related]
59. Common Etiologies of Upper Extremity Spasticity.
Angulo-Parker FJ; Adkinson JM
Hand Clin; 2018 Nov; 34(4):437-443. PubMed ID: 30286958
[TBL] [Abstract][Full Text] [Related]
60. A proposed staging system for amyotrophic lateral sclerosis.
Roche JC; Rojas-Garcia R; Scott KM; Scotton W; Ellis CE; Burman R; Wijesekera L; Turner MR; Leigh PN; Shaw CE; Al-Chalabi A
Brain; 2012 Mar; 135(Pt 3):847-52. PubMed ID: 22271664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
